Skip To Main Content

The News


OCGC Has Closed Its 24th Investment

January 31, 2012

The Ontario Capital Growth Corporation (OCGC) is pleased to advise that it has closed its 24th investment under the Ontario Emerging Technologies Fund (OETF).

Xagenic Inc.

Xagenic Inc. is a molecular diagnostics company located in Toronto, Canada. The company is developing a fully automated technology platform that will enable widespread decentralized diagnostic testing to be performed outside of clinical laboratories. Tests are under development that will allow the detection of a variety of analytes in situations where rapid test turnaround will provide clinically actionable results that dramatically improve patient care and reduce health care costs. The Qualified Investor is CTI Life Sciences Fund L.P.

To learn more about Xagenic Inc., visit www.xagenic.com.

To learn more about CTI Life Sciences Fund L.P., visit www.ctisciences.com.